Error: Could not add to watchlist. X

Axovant Sciences Ltd

+ Watchlist
3AS:GR
Munich
10.37
EUR
0.06
0.57%
As of 02:09:36 ET on 08/31/2015.
Open
10.76
Day Range
10.36 - 10.76
Volume
0
Previous Close
10.31
52Wk Range
8.95 - 26.90
Open
10.76
Day Range
10.36 - 10.76
Volume
0
Previous Close
10.31
52Wk Range
8.95 - 26.90
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (b EUR)
1.028
Shares Outstanding (m)
99.150
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Axovant Sciences Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurological disorders. Axovant Sciences develops products to treat the cognitive impairment and behavioral disturbances associated with dementia.
ADDRESS
Clarendon House
2 Church Street
Hamilton, HM 11
Bermuda
PHONE
1-441-295-5950
  • Vivek Ramaswamy
    Chief Executive Officer
  • Mark Altmeyer
    President/Chief Commercial Ofcr
  • Gregory M Weinhoff "Greg"
    Principal Financial Officer
  • Lawrence T Friedhoff
    Chief Development Ofcr
  • Christine Mikail
    CAO/General Counsel
Show More